International Consensus (ICON): allergic reactions to vaccines
Tóm tắt
Từ khóa
Tài liệu tham khảo
Whitney, 2014, Benefits from immunization during the vaccines for children program era - United States, 1994–2013, Mmwr-Morbid Mortal W, 63, 352
Kelso, 2012, Adverse reactions to vaccines practice parameter 2012 update, J Allergy Clin Immunol, 130, 25, 10.1016/j.jaci.2012.04.003
Vanlander, 2014, Anaphylaxis after vaccination of children: review of literature and recommendations for vaccination in child and school health services in Belgium, Vaccine, 32, 3147, 10.1016/j.vaccine.2014.03.096
RedBook. Red Book 2015: Report of the Committee on Infectious Diseases 30 ed. American Academy of Pediatrics; 2015.
Bohlke, 2003, Risk of anaphylaxis after vaccination of children and adolescents, Pediatrics, 112, 815, 10.1542/peds.112.4.815
Zent, 2002, Immediate allergic reactions after vaccinations--a post-marketing surveillance review, Eur J Pediatr, 161, 21, 10.1007/s00431-001-0853-0
Erlewyn-Lajeunesse, 2012, Anaphylaxis as an adverse event following immunisation in the UK and Ireland, Arch Dis Child, 97, 487, 10.1136/archdischild-2011-301163
Cheng, 2015, Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013, Vaccine, 33, 1602, 10.1016/j.vaccine.2015.02.008
Lotvall, 2012, We call for iCAALL: International Collaboration for Asthma, Allergy and Immunology, Ann Allergy Asthma Immunol, 108, 215, 10.1016/j.anai.2012.02.025
Lotvall, 2012, We call for iCAALL: International Collaboration in Asthma, Allergy and Immunology, J Allergy Clin Immunol, 129, 904, 10.1016/j.jaci.2012.02.009
Lotvall, 2012, We call for iCAALL: International Collaboration in Asthma, Allergy Immunol Allergy, 67, 449, 10.1111/j.1398-9995.2012.02813.x
Lotvall, 2012, We Call for iCAALL: International Collaboration in Asthma, Allergy and Immunology, World Allergy Organ J, 5, 39, 10.1097/WOX.0b013e3182504245
Kroger, 2011, General recommendations on immunization, MMWR Recomm Rep, 60, 1
Johansson, 2001, A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force, Allergy, 56, 813, 10.1034/j.1398-9995.2001.t01-1-00001.x
Simons, 2014, International consensus on (ICON) anaphylaxis, World Allergy Organ J, 7, 9, 10.1186/1939-4551-7-9
Sampson, 2006, Second symposium on the definition and management of anaphylaxis: summary report--Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium, J Allergy Clin Immunol, 117, 391, 10.1016/j.jaci.2005.12.1303
Ruggeberg, 2007, Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data, Vaccine, 25, 5675, 10.1016/j.vaccine.2007.02.064
Simons, 2015, Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years), J Allergy Clin Immunol, 135, 1125, 10.1016/j.jaci.2014.09.014
Simons, 2008, Anaphylaxis epidemic: fact or fiction?, J Allergy Clin Immunol, 122, 1166, 10.1016/j.jaci.2008.10.019
Simons, 2011, Anaphylaxis pathogenesis and treatment, Allergy, 66, 31, 10.1111/j.1398-9995.2011.02629.x
Lee, 2000, Biphasic anaphylactic reactions in pediatrics, Pediatrics, 106, 762, 10.1542/peds.106.4.762
Lieberman, 2005, Biphasic anaphylactic reactions, Ann Allergy Asthma Immunol, 95, 217, 10.1016/S1081-1206(10)61217-3
Vinuya, 1994, Elevated serum tryptase levels in a patient with protracted anaphylaxis, Ann Allergy, 73, 232
Muraro, 2014, Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology, Allergy, 69, 1026, 10.1111/all.12437
Pumphrey, 2000, Lessons for management of anaphylaxis from a study of fatal reactions, Clin Exp Allergy, 30, 1144, 10.1046/j.1365-2222.2000.00864.x
Lieberman, 2010, The diagnosis and management of anaphylaxis practice parameter: 2010 update, J Allergy Clin Immunol, 126, 477, 10.1016/j.jaci.2010.06.022
Cheifetz, 2003, The incidence and management of infusion reactions to infliximab: a large center experience, Am J Gastroenterol, 98, 1315, 10.1111/j.1572-0241.2003.07457.x
Brown, 2014, Anaphylaxis, 1237
Buettcher, 2007, Hypotonic-hyporesponsive episode (HHE) as an adverse event following immunization in early childhood: case definition and guidelines for data collection, analysis, and presentation, Vaccine, 25, 5875, 10.1016/j.vaccine.2007.04.061
2008, Syncope after vaccination--United States, January 2005-July 2007, MMWR Morb Mortal Wkly Rep, 57, 457
Statement regarding interim findings of WHO assessment of deaths of children in Idleb Governorate, Syria. http://www.emro.who.int/entity/vpi/index.html. Accessed Aug 2016.
Sood, 1995, Adverse reactions after measles vaccination in India, Natl Med J India, 8, 208
Orr, 2002, Supplementary statement for the 2002–2003 influenza season: update on oculo-respiratory syndrome in association with influenza vaccination, Can Commun Dis Rep, 28, 1
De Serres, 2005, Oculo-respiratory syndrome after influenza vaccination: trends over four influenza seasons, Vaccine, 23, 3726, 10.1016/j.vaccine.2005.01.154
Skowronski, 2003, Oculo-respiratory syndrome: a new influenza vaccine-associated adverse event?, Clin Infect Dis, 36, 705, 10.1086/367667
Stratton KR, Howe CI, Johnston RB. Adverse events associated with childhood vaccines: evidence bearing on causality. Washington: National Academy Press; 1994.
Gold, 2010, Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study, Vaccine, 28, 4487, 10.1016/j.vaccine.2010.04.041
Steinke, 2015, The alpha-gal story: lessons learned from connecting the dots, J Allergy Clin Immunol, 135, 589, 10.1016/j.jaci.2014.12.1947
Pinson, 2015, Safe administration of a gelatin-containing vaccine in an adult with galactose-alpha-1,3-galactose allergy, Vaccine, 33, 1231, 10.1016/j.vaccine.2015.01.020
Kelso, 2013, Allergic reactions after immunization, Ann Allergy Asthma Immunol, 110, 397, 10.1016/j.anai.2013.03.001
Anonymous. CDC: Possible side effects of vaccines. http://www.cdc.gov/vaccines/vac-gen/side-effects.htm. Accessed Aug 2016.
Anonymous. WHO: Adverse Events Following Vaccines. http://www.who.int/vaccine_safety/initiative/detection/en/. Accessed Aug 2016.
Halsey, 2002, The science of evaluation of adverse events associated with vaccination, Semin Pediatr Infect Dis, 13, 205, 10.1053/spid.2002.125864
Halsey, 2012, Algorithm to assess causality after individual adverse events following immunizations, Vaccine, 30, 5791, 10.1016/j.vaccine.2012.04.005
Tozzi, 2013, Assessment of causality of individual adverse events following immunization (AEFI): a WHO tool for global use, Vaccine, 31, 5041, 10.1016/j.vaccine.2013.08.087
Stratton K, Ford A, Rusch E, Clayton EW. Adverse Effects of Vaccines: Evidence and Causality. Washington: The National Academies Press; 2012. http://iom.nationalacademies.org/Reports/2011/Adverse-Effects-of-Vaccines-Evidence-and-Causality.aspx.
Brighton Collaboration Anaphylaxis Working G. https://brightoncollaboration.org/public/what-we-do/setting-standards/case-definitions/available-definitions.html. Accessed Aug 2016.
Jackson, 2011, Injection site and risk of medically attended local reactions to acellular pertussis vaccine, Pediatrics, 127, e581, 10.1542/peds.2010-1886
Beveridge, 2012, Local vaccine site reactions and contact allergy to aluminum, Pediatr Dermatol, 29, 68, 10.1111/j.1525-1470.2011.01541.x
Bergfors, 2013, Sixty-four children with persistent itching nodules and contact allergy to aluminium after vaccination with aluminium-adsorbed vaccines-prognosis and outcome after booster vaccination, Eur J Pediatr, 172, 171, 10.1007/s00431-012-1841-2
Jackson, 2002, Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids, Pediatr Infect Dis J, 21, 781, 10.1097/00006454-200208000-00016
Nakayama, 1999, A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis vaccine combined with diphtheria and tetanus toxoids, J Allergy Clin Immunol, 103, 321, 10.1016/S0091-6749(99)70508-7
Nakayama T, Aizawa, C. Change in gelatin content of vaccines associated with reduction in reports of allergic reactions. J Allergy Clin Immunol. 2000; 106:591-592.
Pool, 2002, Prevalence of anti-gelatin IgE antibodies in people with anaphylaxis after measles-mumps rubella vaccine in the United States, Pediatrics, 110, 10.1542/peds.110.6.e71
King, 2009, Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6–59 months, Vaccine, 27, 6589, 10.1016/j.vaccine.2009.08.032
Seqirus, Inc. Flucelvax package insert. Holly Springs: Seqirus, Inc.; 2012. http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM329134.pdf. Accessed Aug 2016.
Maglione, 2014, Safety of vaccines used for routine immunization of U.S. children: a systematic review, Pediatrics, 134, 325, 10.1542/peds.2014-1079
Halsey, 2013, Immediate hypersensitivity reactions following monovalent 2009 pandemic influenza A (H1N1) vaccines: reports to VAERS, Vaccine, 31, 6107, 10.1016/j.vaccine.2013.09.066
Kawai, 2014, Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barre syndrome, encephalitis, or anaphylaxis in the 2012–2013 season, Pharmacoepidemiol Drug Saf, 23, 548, 10.1002/pds.3575
Ropero-Alvarez, 2015, Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean, Vaccine, 33, 187, 10.1016/j.vaccine.2014.10.070
Gagnon, 2010, Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine, J Allergy Clin Immunol, 126, 317, 10.1016/j.jaci.2010.05.037
Schuler, 2011, Administration of the adjuvanted pH1N1 vaccine in egg-allergic children at high risk for influenza A/H1N1 disease, Can J Public Health, 102, 196, 10.1007/BF03404895
Vasu, 2008, Adverse events associated with intranasal influenza vaccine in the United States, Ther Adv Respir Dis, 2, 193, 10.1177/1753465808093933
Lee-Wong, 2005, A generalized reaction to thimerosal from an influenza vaccine, Ann Allergy Asthma Immunol, 94, 90, 10.1016/S1081-1206(10)61292-6
Rouleau, 2012, Allergic symptoms after pandemic influenza vaccination rarely mediated by vaccine-specific IgE, J Allergy Clin Immunol, 130, 1423, 10.1016/j.jaci.2012.07.019
Anonymous. Statement on Seasonal Influenza Vaccine for 2015–2016. In:An Advisory Committee Statement (ACS). Publick Health Agency of Canada. 2015. http://www.phac-aspc.gc.ca/naci-ccni/flu-2015-grippe-eng.php. Accessed Aug 2016.
Carapetis, 2001, MMR immunisation. True anaphylaxis to MMR vaccine is extremely rare, BMJ, 323, 869, 10.1136/bmj.323.7317.869a
Kuno-Sakai, 2003, Removal of gelatin from live vaccines and DTaP-an ultimate solution for vaccine-related gelatin allergy, Biologicals, 31, 245, 10.1016/S1045-1056(03)00063-0
D'Souza, 2000, Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign, Commun Dis Intell, 24, 27
Bruno, 1990, Safety of measles immunisation in children with IgE-mediated egg allergy, Lancet, 335, 739, 10.1016/0140-6736(90)90863-Z
Khakoo, 2000, Recommendations for using MMR vaccine in children allergic to eggs, BMJ, 320, 929, 10.1136/bmj.320.7239.929
Esteghamati, 2011, Adverse reactions following immunization with MMR vaccine in children at selected provinces of Iran, Arch Iran Med, 14, 91
Andersen, 2013, MMR vaccination of children with egg allergy is safe, Dan Med J, 60, A4573
Fina Aviles, 2007, MMR vaccine and egg allergy. Experience in a hospital immunization unit, An Pediatr (Barc), 67, 362
Patja, 2001, Allergic reactions to measles-mumps-rubella vaccination, Pediatrics, 107, 10.1542/peds.107.2.e27
Fasano, 1992, Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine, J Pediatr, 120, 878, 10.1016/S0022-3476(05)81953-5
James, 1995, Safe administration of the measles vaccine to children allergic to eggs, N Engl J Med, 332, 1262, 10.1056/NEJM199505113321904
Cronin, 2012, A review of a paediatric emergency department vaccination programme for patients at risk of allergy/anaphylaxis, Acta Paediatr, 101, 941, 10.1111/j.1651-2227.2012.02737.x
Sharrar, 2000, The postmarketing safety profile of varicella vaccine, Vaccine, 19, 916, 10.1016/S0264-410X(00)00297-8
Wise, 2000, Postlicensure safety surveillance for varicella vaccine, JAMA, 284, 1271, 10.1001/jama.284.10.1271
Sakaguchi, 1997, IgE-mediated systemic reactions to gelatin included in the varicella vaccine, J Allergy Clin Immunol, 99, 263, 10.1016/S0091-6749(97)70108-8
Sakaguchi, 2000, Systemic allergic reactions to gelatin included in vaccines as a stabilizer, Jpn J Infect Dis, 53, 189
Ozaki, 2005, Safety and immunogenicity of gelatin-free varicella vaccine in epidemiological and serological studies in Japan, Vaccine, 23, 1205, 10.1016/j.vaccine.2004.08.040
Rabe, 2015, Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009–2012, Vaccine, 33, 708, 10.1016/j.vaccine.2014.11.046
Intercell. JE-VC Package Insert. Intercell Biomedical (Unitred Kingdom). 2013.
Bollinger, 1999, Protamine allergy as a complication of insulin hypersensitivity: a case report, J Allergy Clin Immunol, 104, 462, 10.1016/S0091-6749(99)70394-5
Dobardzic, 2007, Safety review of the purified chick embryo cell rabies vaccine: data from the Vaccine Adverse Event Reporting System (VAERS), 1997–2005, Vaccine, 25, 4244, 10.1016/j.vaccine.2007.02.075
Majchrowicz, 1989, Post-vaccination reactions to diploid rabies vaccine, Przegl Epidemiol, 43, 259
Haditsch, 2013, Tick-borne encephalitis: a disease neglected by travel medicine, Travel Med Infect Dis, 11, 295, 10.1016/j.tmaid.2013.07.003
Suss, 2011, Tick-borne encephalitis 2010: epidemiology, risk areas, and virus strains in Europe and Asia-an overview, Ticks Tick Borne Dis, 2, 2, 10.1016/j.ttbdis.2010.10.007
Bogovic, 2015, Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management, World J Clin Cases, 3, 430, 10.12998/wjcc.v3.i5.430
Zent, 2003, Clinical evaluation of a polygeline-free tick-borne encephalitis vaccine for adolescents and adults, Vaccine, 21, 738, 10.1016/S0264-410X(02)00592-3
Loew-Baselli, 2006, Safety and immunogenicity of the modified adult tick-borne encephalitis vaccine FSME-IMMUN: results of two large phase 3 clinical studies, Vaccine, 24, 5256, 10.1016/j.vaccine.2006.03.061
Canadian Immunization Guide. 2015. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/06vol32/acs-03/index-eng.php.
Arroabarren, 2016, Anaphylaxis to pneumococcal vaccine; CRM(197): novel cause of vaccine allergy, Pediatr Allergy Immunol, 27, 433, 10.1111/pai.12548
Nelson, 2000, Anaphylaxis complicating routine childhood immunization: hemophilus influenza b conjugated vaccine, Pediatric Asthma, Allergy & Immunology, 14, 315, 10.1089/088318700750070411
Finn, 2008, Vaccine additives and manufacturing residuals in United States licensed vaccines, 73
Anonymous. Allergens in Vaccines. Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Publick Health. 2015. http://www.vaccinesafety.edu/components-Allergens.htm. Accessed Aug 2016.
Bergfors, 2014, How common are long-lasting, intensely itching vaccination granulomas and contact allergy to aluminium induced by currently used pediatric vaccines? A prospective cohort study, Eur J Pediatr, 173, 1297, 10.1007/s00431-014-2318-2
Gente Lidholm, 2013, Unexpected loss of contact allergy to aluminium induced by vaccine, Contact Dermatitis, 68, 286, 10.1111/cod.12053
Chong, 2006, Persistent nodules at injection sites (aluminium granuloma) -- clinicopathological study of 14 cases with a diverse range of histological reaction patterns, Histopathology, 48, 182, 10.1111/j.1365-2559.2005.02312.x
Rouleau, 2013, Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine, Vaccine, 31, 5989, 10.1016/j.vaccine.2013.10.033
Rouleau, 2014, Risk factors associated with anaphylaxis and other allergic-like events following receipt of 2009 monovalent AS03-adjuvanted pandemic influenza vaccine in Quebec, Canada, Vaccine, 32, 3480, 10.1016/j.vaccine.2014.04.059
Stassijns, 2016, A systematic review and meta-analysis on the safety of newly adjuvanted vaccines among children, Vaccine, 34, 714, 10.1016/j.vaccine.2015.12.024
Seqirus I. FLUAD, Package Insert. 2016.
Fritsche, 2010, Vaccine hypersensitivity--update and overview, Swiss Med Wkly, 140, 238
Leventhal, 2012, Hypersensitivity reactions to vaccine constituents: a case series and review of the literature, Dermatitis, 23, 102, 10.1097/DER.0b013e31825228cf
Zheng, 2007, Thimerosal in influenza vaccine: an immediate hypersensitivity reaction, Ann Allergy Asthma Immunol, 99, 574, 10.1016/S1081-1206(10)60391-2
Lear, 1995, Anaphylaxis after hepatitis B vaccination, Lancet, 345, 1249, 10.1016/S0140-6736(95)92039-0
Russell, 2004, Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS), Vaccine, 23, 664, 10.1016/j.vaccine.2004.06.042
Hamborsky J, Kroger A, Wolfe C. Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. The Pink Book. Washington, DC: Centers for Disease Control and Prevention; Public Health Foundation; 2015. Also, http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/B/latex-table.pdf. Accessed Aug 2016.
Kelso, 2012, Safety of influenza vaccines, Curr Opin Allergy Clin Immunol, 12, 383, 10.1097/ACI.0b013e328354395d
Kelso, 2009, Adverse reactions to vaccines, Ann Allergy Asthma Immunol, 103, S1, 10.1016/S1081-1206(10)60350-X
Wood, 2008, An algorithm for treatment of patients with hypersensitivity reactions after vaccines, Pediatrics, 122, e771, 10.1542/peds.2008-1002
Caubet, 2014, Managing a child with possible allergy to vaccine, Pediatr Allergy Immunol, 25, 394, 10.1111/pai.12132
Ponvert, 2001, Anaphylaxis to the 23-valent pneumococcal vaccine in child: a case–control study based on immediate responses in skin tests and specific IgE determination, Vaccine, 19, 4588, 10.1016/S0264-410X(01)00257-2
Wood, 2007, Irritant skin test reactions to common vaccines, J Allergy Clin Immunol, 120, 478, 10.1016/j.jaci.2007.04.035
Ponvert, 2009, Allergic and non-allergic hypersensitivity reactions to toxoid-containing vaccines, Arch Pediatr, 16, 391, 10.1016/j.arcped.2009.01.002
Grohskopf, 2014, Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) -- United States, 2014–15 influenza season, MMWR Morb Mortal Wkly Rep, 63, 691
Kelso, 2000, Raw egg allergy-a potential issue in vaccine allergy, J Allergy Clin Immunol, 106, 990, 10.1067/mai.2000.110800
Merck & Co. I. M-M-R II Package Insert. Merck & Co., Inc.; 2014. Also, https://www.merck.com/product/usa/pi_circulars/m/mmr_ii/mmr_ii_pi.pdf. Accessed Aug 2016.
Novartis, Inc. RabAvert package insert. Basil: Novartis, Inc; 2013.Also, http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM312931.pdf. Accessed Aug 2016.
Herman, 1983, Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein, J Pediatr, 102, 196, 10.1016/S0022-3476(83)80519-8
O'Brien, 1971, Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion, Appl Microbiol, 21, 780, 10.1128/am.21.4.780-782.1971
Kelso, 2014, Administering influenza vaccine to egg-allergic persons, Expert Rev Vaccines, 13, 1049, 10.1586/14760584.2014.933079
Baxter, 1996, Measles immunization in children with a history of egg allergy, Vaccine, 14, 131, 10.1016/0264-410X(95)00154-S
McLean, 2013, Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 62, 1
Fiore, 2010, Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010, MMWR Recomm Rep, 59, 1
Lee, 2011, H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project, Am J Prev Med, 41, 121, 10.1016/j.amepre.2011.04.004
Tavares, 2011, Anaphylaxis following H1N1 pandemic vaccines: safety data in perspective, Vaccine, 29, 6402, 10.1016/j.vaccine.2011.04.026
Woo, 2015, Allergic reactions after egg-free recombinant influenza vaccine: reports to the US Vaccine Adverse Event Reporting System, Clin Infect Dis, 60, 777, 10.1093/cid/ciu948
Anonymous. European pharmacopia, 5.8 CD, 7/2007. Strasbourg, France: Euorpiean Directoriate for the Quality of Medicines and Health Care; 2007.
Vajo, 2012, A reduced-dose seasonal trivalent influenza vaccine is safe and immunogenic in adult and elderly patients in a randomized controlled trial, Clin Vaccine Immunol, 19, 313, 10.1128/CVI.05619-11
Kelso, 2013, Update on influenza vaccination of egg allergic patients, Ann Allergy Asthma Immunol, 111, 301, 10.1016/j.anai.2013.07.030
Des Roches, 2015, Safe vaccination of patients with egg allergy by using live attenuated influenza vaccine, J Allergy Clin Immunol In practice, 3, 138, 10.1016/j.jaip.2014.08.008
Turner, 2015, Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study, BMJ, 351, h6291, 10.1136/bmj.h6291
Turner, 2015, Safety of live attenuated influenza vaccine in atopic children with egg allergy, J Allergy Clin Immunol, 10.1016/j.jaci.2014.12.1925
Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–2016 Influenza Season. Centers for Disease Control and Prevention. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6430a3.htm?s_cid=mm6430a3_e. Accessed Aug 2016.
SanofiPasteur. YF-VAX Package Insert. Sanofi Pasteur; Lyon, France. 2013. Also, https://www.vaccineshoppe.com/image.cfm?doc_id=13709&image_type=product_pdf. Accessed Aug 2016.
Kelso, 1999, Common allergens in avian meats, J Allergy Clin Immunol, 104, 202, 10.1016/S0091-6749(99)70136-3
Kelso, 1999, Anaphylaxis from yellow fever vaccine, J Allergy Clin Immunol, 103, 698, 10.1016/S0091-6749(99)70245-9
Munoz-Cano, 2010, Yellow fever vaccine and egg allergy: really a problem?, Allergy, 65, 533, 10.1111/j.1398-9995.2009.02205.x
Rutkowski, 2013, Administration of yellow fever vaccine in patients with egg allergy, Int Arch Allergy Immunol, 161, 274, 10.1159/000346350
Sakaguchi, 1996, Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines, J Allergy Clin Immunol, 98, 1058, 10.1016/S0091-6749(96)80191-6
Sakai, 1998, Non-antigenic and low allergic gelatin produced by specific digestion with an enzyme-coupled matrix, Biol Pharm Bull, 21, 330, 10.1248/bpb.21.330
Bogdanovic, 2009, Bovine and porcine gelatin sensitivity in children sensitized to milk and meat, J Allergy Clin Immunol, 124, 1108, 10.1016/j.jaci.2009.06.021
Kelso, 1993, Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin, J Allergy Clin Immunol, 91, 867, 10.1016/0091-6749(93)90344-F
Kumagai, 1997, Gelatin-specific humoral and cellular immune responses in children with immediate- and nonimmediate-type reactions to live measles, mumps, rubella, and varicella vaccines, J Allergy Clin Immunol, 100, 130, 10.1016/S0091-6749(97)70204-5
Sakaguchi, 1995, IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines, J Allergy Clin Immunol, 96, 563, 10.1016/S0091-6749(95)70304-7
Singer, 1999, Urticaria following varicella vaccine associated with gelatin allergy, Vaccine, 17, 327, 10.1016/S0264-410X(98)00209-6
Sakaguchi, 1997, Systemic immediate-type reactions to gelatin included in Japanese encephalitis vaccines, Vaccine, 15, 121, 10.1016/S0264-410X(96)00170-3
Worm, 2000, Gelatin-induced urticaria and anaphylaxis after tick-borne encephalitis vaccine, Acta Derm Venereol, 80, 232, 10.1080/000155500750043186
Nagel, 2006, New gelatine-free TBE vaccines with improved safety profile, Klin Padiatr, 218, 379, 10.1055/s-2006-942201
Nakayama, 2000, Change in gelatin content of vaccines associated with reduction in reports of allergic reactions, J Allergy Clin Immunol, 106, 591, 10.1067/mai.2000.108433
Kattan, 2011, Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow's milk allergy, J Allergy Clin Immunol, 128, 215, 10.1016/j.jaci.2011.04.046
Parisi, 2013, Hypersensitivity reactions to the Sabin vaccine in children with cow's milk allergy, Clin Exp Allergy, 43, 249, 10.1111/cea.12059
Kelso, 2014, Potential food allergens in medications, J Allergy Clin Immunol, 133, 1509, 10.1016/j.jaci.2014.03.011
Slater, 2011, Comments on cow's milk allergy and diphtheria, tetanus, and pertussis vaccines, J Allergy Clin Immunol, 128, 434, 10.1016/j.jaci.2011.06.028
Quirce, 2013, Diagnosis and management of grain-induced asthma, Allergy, Asthma Immunol Res, 5, 348, 10.4168/aair.2013.5.6.348
Baur, 1998, Baker's asthma: still among the most frequent occupational respiratory disorders, J Allergy Clin Immunol, 102, 984, 10.1016/S0091-6749(98)70337-9
Belchi-Hernandez, 1996, Baker's asthma caused by Saccharomyces cerevisiae in dry powder form, J Allergy Clin Immunol, 97, 131, 10.1016/S0091-6749(96)70293-2
Airola, 2006, Clustered sensitivity to fungi: anaphylactic reactions caused by ingestive allergy to yeasts, Ann Allergy Asthma Immunol, 97, 294, 10.1016/S1081-1206(10)60792-2
Bielory, 2014, Unconventional Theories and Unproven Methods in Allergy, 1616
GlaxoSmithKline. ENGERIX-B Package Insert. Mississauga, Ontario, Canada. 2013.Also, http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM224503.pdf. Accessed Aug 2016.
Merck & Co. I. RECOMBIVAX HB Package Insert. Merck, Inc. Kenilworth, NJ USA. 2014.Also, https://www.merck.com/product/usa/pi_circulars/r/recombivax_hb/recombivax_pi.pdf. Accessed Aug 2016.
Merck & Co. I. GARDASIL Package Insert. Merck, Inc. Kenilworth, NJ USA. 2011.Also,http://www.fda.gov/downloads/BiologicsBloodVaccines/Vaccines/ApprovedProducts/UCM111263.pdf. Accessed August 2016.
DiMiceli, 2006, Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS), Vaccine, 24, 703, 10.1016/j.vaccine.2005.07.069
Anonymous. Latex in Vaccine Packaging. In: Atkinson WL, Wolfe S, Hmborsky J, editors. Epidemiology and Prevention of Vaccine-Preventable Diseases. 12th ed. Washington: Centers for Disease Control and Prevention; 2012.
Yunginger, 1994, Extractable latex allergens and proteins in disposable medical gloves and other rubber products, J Allergy Clin Immunol, 93, 836, 10.1016/0091-6749(94)90374-3
Hamilton, 2005, Administering pharmaceuticals to latex-allergic patients from vials containing natural rubber latex closures, Am J Health Syst Pharm, 62, 1822, 10.2146/ajhp050021